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Ms Body Mass Index Really the Best
easure of Obesity in Individuals?
n the August 19, 2008, edition of the Journal, Gelber et al. (1)
resent data from the Physician’s and Women’s Health studies and
onclude that, although waist-to-height ratio (WHtR) has the
trongest gradient in the association with incident cardiovascular
isease (CVD), “differences between BMI [body mass index] and
HtR in association with CVD. . .[are] small and likely not
linically consequential.” They suggest that “BMI may remain the
ost clinically practical measure of adiposity.” Litwin (2), in an
ccompanying editorial, makes the general argument that “clinical
racticality is frequently overshadowed by statistical significance”
nd that, in the interests of clarity and to avoid equivocation, BMI
hould be retained as the principal and universal measure of obesity.
A critical point is being missed here, which relates to the
ranslation of measures from large population studies to the
anagement of the individual. In large population studies per-
ormed in adults, BMI provides a useful surrogate index of obesity
ecause it corrects for individuals who are heavy by virtue of the
act that they are also tall. In large population studies, a higher
MI might reasonably be assumed due to excess fat mass. Of
ourse it is accepted that BMI provides no information regarding
he composition of the weight, or its distribution, but this does not
atter so much when the study is performed in 49,000 subjects.
owever, populations are comprised of individuals, and it is
ndividuals we treat. In adults, body height does not change over
ime, so BMI reverts to a measure of gross body weight in the
ndividual. Is it valid to simply measure body weight as an index of
atness when following up patients? If so, why do we measure BMI
n the clinic at all?
Moreover, changes in BMI in the individual cannot be appro-
riately used as an index of change in obesity or cardiovascular risk.
o make the point using a relevant example, exercise is an
ntervention that is widely prescribed for obese subjects. It is also
n intervention that can increase skeletal muscle and lean body
ass. Exercise studies often result in no change in body weight or
MI, whereas sensitive imaging modalities reveal significant de-
reases in fat mass, including abdominal fat mass (3). Exercise has
ountervailing impacts on fat and lean body mass (4), which render
MI meaningless as an index of obesity, adiposity, or risk in
ndividuals.
Consideration of changes in body composition, rather than
easures of body weight, including BMI, remains important, and
his may be one reason to use the WHtR index, in preference to
MI, as a simple, uncomplicated measure that moves patients
efficiently through our offices.”
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roblems in Measurement
f Body “Fatness”
elber et al. (1) make an important contribution in comparing
nthropometric measurements as predictors of cardiovascular dis-
ase (CVD). These authors and an editorialist (2), accept that
fatness” relates to CVD, and point out the controversy regarding
otal fat content versus some “central” fat accumulation in promot-
ng CVD. Both entertain reservations as to whether body mass
ndex (BMI) measures general obesity or whether waist circum-
erence (WC) (or some modification, such as waist-to-hip ratio
WHR] or waist-to-height [WHtR]) measures “central” obesity.
BMI, calculated from body weight and height2, does not
eparate the components of its 2-compartment model: lean body
ass (LBM) and total body fat (WF). Equating elevated BMI
ith “obesity” or “adiposity” incorrectly assumes that LBM is
onstant at any given height so that any BMI change represents a
hange of WF. Gelber et al. (1) and Litwin (2) are aware of this,
ut perhaps not of the resulting magnitude and frequency of
otential error. Using a direct measurement of body fat, within a
omogeneous cohort of similar height, LBM varies at least 20%
rom the group mean, and an individual’s deviation from average
eight at this height can be all WF, all LBM, or any combination
f these (3). For young women of identical height, weight, and
MI, a20% range of LBM is associated with a remarkable range
f fat content (WF/body weight), from 10% to 40% (calculated
rom Lesser et al. [3]).
The interpretation of BMI (and, to a lesser extent, of WHR and
HtR) is further complicated by aging changes within the LBM.
he Gelber et al. (1) subjects were in the fifth to ninth decades.
ost older people lose muscle and bone mass; many also loseppreciable height (4). Such LBM changes vary widely among
